TY - JOUR AU - de Vries, Arjen E AU - van der Wal, Martje H.L AU - Nieuwenhuis, Maurice M.W AU - de Jong, Richard M AU - van Dijk, Rene B AU - Jaarsma, Tiny AU - Hillege, Hans L PY - 2013 DA - 2013/01/10 TI -基于互联网的远程监测的卫生专业人员的期望与经验:调查在心力衰竭诊所JO - J医学互联网Res SP - e4 VL - 15 IS - 1kw -远程监护，远程医疗，远程监护，互联网，心力衰竭，心力衰竭管理，疾病管理，AB -背景:虽然远程监护越来越多地应用于心力衰竭治疗，但关于远程监护的期望、经验和组织意义的数据很少被提及，并且能够从远程监护中受益的患者的最佳配置尚未确定。目的:评估远程监护的实际使用状况，描述荷兰心力衰竭远程监护工作中涉及的期望、经验和组织方面。方法:与荷兰应用科学研究组织(TNO)合作，向荷兰所有门诊心衰诊所发送了一份19项调查，对象是在诊所工作的心脏科医生和心衰护士。结果:在109家接受调查的心衰诊所中，86家诊所做出了回应(79%)。总的来说，86家心力衰竭诊所中有31家(36%)正在使用远程监护，12家心力衰竭诊所(14%)计划在一年内使用远程监护。接受远程监护的心力衰竭患者数量一般在10到50之间;尽管在两家诊所有超过75名患者使用了远程监护。使用远程监护的主要目标是“监测身体状况”、“监测病情恶化迹象”(n= 39,91%)、“监测治疗”(n= 32,74%)、“调整用药”(n= 24,56%)和“教育患者”(n= 33,77%)。 Most patients using telemonitoring were in the New York Heart Association (NYHA) functional classes II (n=19, 61%) and III (n=27, 87%) and were offered the use of the telemonitoring system “as long as needed” or without a time limit. However, the expectations of the use of telemonitoring were not met after implementation. Eight of the 11 items about expectations versus experiences were significantly decreased (P<.001). Health care professionals experienced the most changes related to the use of telemonitoring in their work, in particular with respect to “keeping up with current development” (before 7.2, after 6.8, P=.15), “being innovative” (before 7.0, after 6.1, P=.003), and “better guideline adherence” (before 6.3, after 5.3, P=.005). Strikingly, 20 out of 31 heart failure clinics stated that they were considering using a different telemonitoring system than the system used at the time. Conclusions: One third of all heart failure clinics surveyed were using telemonitoring as part of their care without any transparent, predefined criteria of user requirements. Prior expectations of telemonitoring were not reflected in actual experiences, possibly leading to disappointment. SN - 1438-8871 UR - //www.mybigtv.com/2013/1/e4/ UR - https://doi.org/10.2196/jmir.2161 UR - http://www.ncbi.nlm.nih.gov/pubmed/23305645 DO - 10.2196/jmir.2161 ID - info:doi/10.2196/jmir.2161 ER -